# Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers

> **NCT03003065** · PHASE2 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 10 (actual)

## Conditions studied

- Cholangiocarcinoma
- Tumor
- Klatskin Tumor

## Interventions

- **DRUG:** Temoporfin

## Key facts

- **NCT ID:** NCT03003065
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-28
- **Primary completion:** 2023-04-12
- **Final completion:** 2023-08-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03003065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03003065, "Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03003065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*